Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Nurse-Led Telehealth Frailty Management in Older Adults

1 de noviembre de 2026 actualizado por: Kutahya Health Sciences University

The Effect of a Nurse-Led Telehealth-Supported Multicomponent Frailty Management Program on Frailty and Functional Status in Older Adults Living at Home: A Randomized Controlled Trial

Frailty can make older adults more vulnerable to loss of independence, falls, and hospitalization. This study evaluated whether a six-week nurse-led telephone education and counseling program could improve frailty and daily functioning in older adults living at home.

This single-center, two-arm, parallel-group randomized controlled trial included 122 adults aged 65 years or older who were frail or at risk of frailty and received home care services. Participants were randomly assigned to the intervention group or the usual care group, with 61 participants in each group.

Both groups continued to receive routine monthly home care. In addition, the intervention group received an initial face-to-face session followed by weekly telephone education and counseling sessions lasting approximately 20 to 25 minutes for six weeks. No additional intervention education or counseling was provided during weeks 7 to 18.

The primary outcome was frailty measured using the FRAIL Scale. Secondary outcomes included ability to perform instrumental activities of daily living, depressive symptoms, falls, emergency department visits, and hospitalizations. Frailty, daily functioning, and depressive symptoms were assessed at baseline, week 6, and week 18. Falls and health care use were recorded during the 18-week follow-up period. Outcome assessment and statistical analysis were conducted with treatment-group masking.

Descripción general del estudio

Descripción detallada

The study was conducted through a hospital-based home care unit in Kütahya, Türkiye.

The intervention was delivered by a nurse with a master's degree. It began with an individual face-to-face assessment and education session lasting approximately 20 to 25 minutes, followed by one telephone education and counseling session per week for six weeks. Each telephone session lasted approximately 20 to 25 minutes.

The program addressed frailty awareness, safe physical activity and mobility, nutrition and fluid intake, fall prevention and home safety, medication and chronic disease self-management, sleep and fatigue management, social support, and healthy daily routines. Education and counseling were individualized to participants' needs and supported by an educational booklet and an individual action plan. A standardized checklist was used to document delivery of the intervention content and completion of the sessions. No additional intervention education or counseling was provided during weeks 7 to 18.

Participants in both groups continued routine monthly hospital-based home care services, including assessment of general health, blood pressure, pulse, body temperature, and pressure injuries. Adverse events were monitored weekly in both groups. Reports of deaths were obtained from relatives and reviewed alongside available health records.

Face-to-face outcome assessments were performed at baseline, week 6, and week 18 by a researcher who was unaware of group allocation. Frailty was assessed with the FRAIL Scale, functional status with the Lawton-Brody Instrumental Activities of Daily Living Scale, and depressive symptoms with the 15-item Geriatric Depression Scale. Falls, emergency department visits, and hospitalizations were recorded during follow-up.

Randomization and statistical analysis were performed by different researchers. The statistical analyst received groups coded as A and B and remained unaware of the intervention and control labels during the main analyses. Measurements obtained before withdrawal or death were retained; no measurements were imputed after death.

Tipo de estudio

Intervencionista

Inscripción (Actual)

122

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Kütahya
      • Simav, Kütahya, Turquía (Türkiye), 43500
        • Simav Doc. Dr. Ismail Karakuyu State Hospital Home Care Unit

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

65 años y mayores (Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Aged 65 years or older
  • Living at home and not receiving institutional care
  • Frail or at risk of frailty
  • Having sufficient hearing and cognitive ability to communicate by telephone
  • Able to read, understand, and communicate in Turkish
  • Providing written informed consent

Exclusion Criteria:

  • Having advanced cognitive impairment such as dementia
  • Having hearing or speech problems that prevent communication
  • Being bedridden
  • Being in the terminal stage of illness
  • Participating in another intervention or education program at the same time
  • Having a serious physical or psychiatric condition that may prevent regular participation in the intervention

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Nurse-Led Telehealth-Supported Frailty Management Program

Participants received a six-week nurse-led telehealth-supported frailty management program in addition to routine monthly home care. A nurse with a master's degree delivered an initial face-to-face assessment and education session, followed by weekly telephone education and counseling sessions lasting approximately 20 to 25 minutes. An educational booklet and an individual action plan supported the intervention. Session completion and content delivery were documented using a standardized checklist. No additional intervention education or counseling was provided during weeks 7 to 18.

A six-week individualized education and counseling program delivered by a nurse with a master's degree. An initial face-to-face session and weekly telephone sessions each lasted approximately 20 to 25 minutes. Content addressed frailty awareness, safe physical activity and mobility, nutrition and fluid intake, fall prevention and home safety, medication and chronic disease self-management, sleep and fatigue management, social support, and healthy daily routines. An educational booklet and an individual action plan supported delivery. A standardized checklist documented session completion and content delivery. No additional intervention education or counseling was provided during weeks 7 to 18.

Sin intervención: Usual Care

Participants continued routine monthly hospital-based home care, including assessment of general health, blood pressure, pulse, body temperature, and pressure injuries. They did not receive the structured frailty education and telephone counseling program. Outcome assessments and weekly adverse event monitoring followed the same schedule as in the intervention group.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Frailty Level Assessed by the FRAIL Scale
Periodo de tiempo: Baseline, 6 weeks, and 18 weeks

Frailty level will be assessed using the FRAIL Scale. The FRAIL Scale consists of five components: fatigue, resistance, ambulation, illnesses, and weight loss. Total scores range from 0 to 5. Higher scores indicate greater frailty. A score of 0 indicates robust status, scores of 1 to 2 indicate pre-frailty, and scores of 3 to 5 indicate frailty.

Baseline, 6 weeks, and 18 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Functional Status Assessed by the Lawton-Brody Instrumental Activities of Daily Living Scale
Periodo de tiempo: Baseline, 6 weeks, and 18 weeks

Functional status will be assessed using the Lawton-Brody Instrumental Activities of Daily Living Scale. Total scores range from 0 to 8. Higher scores indicate greater independence in instrumental activities of daily living.

Baseline, 6 weeks, and 18 weeks
Depressive Symptoms Assessed by the 15-Item Geriatric Depression Scale
Periodo de tiempo: Baseline, 6 weeks, and 18 weeks

Depressive symptoms will be assessed using the 15-item Geriatric Depression Scale. Total scores range from 0 to 15. Higher scores indicate more severe depressive symptoms. Scores of 0 to 4 indicate no depression, 5 to 8 indicate mild depression, 9 to 11 indicate moderate depression, and 12 to 15 indicate severe depression.

Baseline, 6 weeks, and 18 weeks
Number of Falls During the Study Period
Periodo de tiempo: From baseline to 18 weeks

The number of falls experienced by participants during the study period will be recorded using a fall and health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates more falls.

From baseline to 18 weeks
Number of Emergency Department Visits During the Study Period
Periodo de tiempo: From baseline to 18 weeks

The number of emergency department visits during the study period will be recorded using a health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates greater emergency health care utilization.

From baseline to 18 weeks
Number of Hospitalizations During the Study Period
Periodo de tiempo: From baseline to 18 weeks

The number of hospitalizations during the study period will be recorded using a health care utilization form developed by the researchers. Data will be based on participant self-report. A higher number indicates greater hospital utilization.

From baseline to 18 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

5 de junio de 2026

Finalización primaria (Actual)

22 de octubre de 2026

Finalización del estudio (Actual)

22 de octubre de 2026

Fechas de registro del estudio

Enviado por primera vez

4 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

4 de junio de 2026

Publicado por primera vez (Actual)

8 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

4 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

1 de noviembre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • KSBU-FRAIL-RCT-2026-01

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

De-identified individual participant data underlying the findings reported in the main publication, together with the associated data dictionary, will be made available to researchers upon reasonable request to the corresponding author for 5 years following publication of the main study article. The data will not be posted publicly to protect participant privacy. Access will be subject to applicable ethical and participant-consent requirements.

Marco de tiempo para compartir IPD

Data will be available from publication of the main study article and will remain available for 5 years.

Criterios de acceso compartido de IPD

Researchers may request access by emailing Serkan Budak at serkan.budak@ksbu.edu.tr and describing the research question, intended analyses, and data required. The corresponding author will review requests for scientific relevance, participant confidentiality, and compliance with applicable ethical and consent requirements. Approved requests will receive de-identified data and the associated data dictionary.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CÓDIGO_ANALÍTICO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir